Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.38
-0.04 (-0.48%)
Apr 9, 2026, 10:31 AM EDT - Market open
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$1,499,972
Profits / Employee
$587,853
Market Cap
1.37B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Immatics | 711 |
| Wave Life Sciences | 317 |
| Biohaven | 274 |
| Zenas BioPharma | 167 |
| Monte Rosa Therapeutics | 150 |
| Olema Pharmaceuticals | 131 |
| MoonLake Immunotherapeutics | 130 |
NVAX News
- 23 hours ago - Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy - Benzinga
- 1 day ago - Shah Capital intends to vote against Novavax's board nominees, executive compensation - Reuters
- 10 days ago - Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development - PRNewsWire
- 5 weeks ago - What's Going On With Novavax Stock On Friday? - Benzinga
- 5 weeks ago - Novavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb - Benzinga
- 6 weeks ago - Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals - Reuters
- 6 weeks ago - Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - PRNewsWire